PUBLISHER: The Business Research Company | PRODUCT CODE: 1948273
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948273
A stereotactic surgical device is a technology utilized to precisely locate specific brain regions by employing a set of three coordinates, all while maintaining the head in a fixed position. This technology plays a crucial role in stereotactic surgery, facilitating the implantation of substances such as medications or hormones into the brain.
The market research report on stereotactic surgical devices is part of a comprehensive series of reports by The Business Research Company. This report offers statistical insights into the stereotactic surgical devices market, encompassing global market size, regional distribution, competitors and their market shares, detailed market segments within the stereotactic surgical devices industry, prevalent market trends, opportunities, and any additional data essential for success in the stereotactic surgical devices sector. Providing a thorough perspective, the research report conducts an in-depth analysis of both current and future scenarios within the industry.
Tariffs are impacting the stereotactic surgery devices market by increasing costs of imported imaging modules, radiation delivery systems, robotic components, and precision control software. Hospitals and specialty neurosurgical centers in North America and Europe are most affected due to reliance on high-end imported systems, while Asia-Pacific faces higher capital costs for technology acquisition. These tariffs are increasing system prices and slowing installation timelines. However, they are also encouraging localized assembly, regional service partnerships, and domestic innovation in stereotactic surgical technologies.
The stereotactic surgery devices market research report is one of a series of new reports from The Business Research Company that provides stereotactic surgery devices market statistics, including stereotactic surgery devices industry global market size, regional shares, competitors with a stereotactic surgery devices market share, detailed stereotactic surgery devices market segments, market trends and opportunities, and any further data you may need to thrive in the stereotactic surgery devices industry. This stereotactic surgery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The stereotactic surgery devices market size has grown strongly in recent years. It will grow from $22.44 billion in 2025 to $23.84 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising prevalence of neurological disorders, expansion of neurosurgical centers, increased use of gamma knife systems, adoption of minimally invasive brain procedures, advancements in medical imaging technologies.
The stereotactic surgery devices market size is expected to see strong growth in the next few years. It will grow to $30.94 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for precision neurosurgery, rising investments in advanced radiosurgery platforms, expansion of AI-assisted surgical planning, growing adoption of non-invasive treatment methods, increasing focus on patient-specific therapy. Major trends in the forecast period include increasing adoption of image-guided stereotactic systems, rising use of robotic-assisted neurosurgical platforms, growing integration of high-precision navigation technologies, expansion of non-invasive radiosurgery solutions, enhanced focus on treatment accuracy and safety.
The rising prevalence of Parkinson's disease and epilepsy is expected to drive the growth of the stereotactic surgical device market in the coming years. Parkinson's disease is a neurodegenerative disorder that leads to involuntary tremors, slow movements, and stiff muscles, while epilepsy is a neurological condition that increases the likelihood of recurring, unprovoked seizures. Stereotactic surgical devices are employed in treating movement disorders, epilepsy, pain, psychiatric conditions, and Parkinson's disease. For example, in November 2024, the British Psychological Society, a UK-based professional body for psychology, reported that in Wales, around 100,000 people live with long-term neurological conditions, including over 41,000 affected by disorders such as Parkinson's disease, epilepsy, multiple sclerosis, muscular dystrophy, motor neurone disease, and cerebral palsy, with approximately 2,500 new cases of Parkinson's disease, epilepsy, multiple sclerosis, or motor neurone disease diagnosed annually. Thus, the increasing incidence of Parkinson's disease and epilepsy is fueling growth in the stereotactic surgical device market.
The expanding geriatric population is also expected to support the growth of the stereotactic surgical device market. The geriatric population comprises elderly individuals, generally defined as those aged 65 and above. Stereotactic surgical devices provide minimally invasive and precise treatment solutions for this demographic, addressing the unique health challenges associated with aging. For example, in October 2025, the World Health Organization (WHO), a Switzerland-based UN agency, projected that by 2030, one in six people globally will be aged 60 or older, with this population expected to double to 2.1 billion by 2050. Therefore, the growing geriatric population is contributing to the expansion of the stereotactic surgical device market.
Major companies in the stereotactic surgical device market are focusing on developing innovative technologies to enhance their market position. For example, in May 2023, Brainlab, a medical technology company based in Germany, introduced a new product named ExacTrac Dynamic Surface. This innovation constitutes a surface-guided radiation therapy (SGRT) patient tracking and positioning system. The system integrates high-speed thermal surface tracking technology with an updated ExacTrac X-ray monitoring feature, providing increased versatility and accuracy in patient positioning and monitoring for various treatments, including cranial and spine stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). The system utilizes a structured blue light pattern on the patient's surface, captured by two 3D cameras, with each surface point augmented by a thermal signature registered by a third in-unit camera.
Major companies operating in the stereotactic surgery devices market are Elekta AB, Varian Medical Systems Inc., Accuray Incorporated, Ion Beam Applications S.A., ZAP Surgical Systems Inc., Brainlab AG, Monteris Medical Holding AG, Renishaw plc, Medtronic plc, Nexstim Plc, FHC Inc., Alpha Omega Engineering Inc., Mitsubishi Heavy Industries Ltd., Inomed Medizintechnik GmbH, MRI Interventions Inc., Modus Medical Devices Inc., Scopis GmbH, Neuropace Inc., Adeor Medical AG, Huiheng Group Co Ltd
North America was the largest region in the stereotactic surgery devices market in 2025. The regions covered in the stereotactic surgery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the stereotactic surgery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The stereotactic surgical device market consists of sales of intracranial drilling, intracranial injections, and brain cannulation. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Stereotactic Surgery Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses stereotactic surgery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for stereotactic surgery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The stereotactic surgery devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.